News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
705,158 Results
Type
Article (41793)
Company Profile (473)
Press Release (662892)
Section
Business (208488)
Career Advice (2013)
Deals (35968)
Drug Delivery (97)
Drug Development (83395)
Employer Resources (169)
FDA (16354)
Job Trends (15055)
News (352282)
Policy (32996)
Tag
Academia (2619)
Alliances (50770)
Alzheimer's disease (1330)
Approvals (16303)
Artificial intelligence (171)
Bankruptcy (363)
Best Places to Work (11800)
Biotechnology (355)
Breast cancer (206)
Cancer (1532)
Cardiovascular disease (128)
Career advice (1678)
CAR-T (109)
Cell therapy (327)
Clinical research (66667)
Collaboration (581)
Compensation (306)
COVID-19 (2607)
C-suite (135)
Data (1485)
Diabetes (189)
Diagnostics (6249)
Earnings (86235)
Employer resources (147)
Events (113812)
Executive appointments (470)
FDA (17123)
Funding (524)
Gene therapy (233)
GLP-1 (651)
Government (4421)
Healthcare (19064)
Infectious disease (2703)
Inflammatory bowel disease (119)
Interviews (309)
IPO (16655)
Job creations (3696)
Job search strategy (1430)
Layoffs (451)
Legal (7942)
Lung cancer (225)
Manufacturing (222)
Medical device (13374)
Medtech (13379)
Mergers & acquisitions (19542)
Metabolic disorders (515)
Neuroscience (1707)
NextGen: Class of 2025 (6746)
Non-profit (4541)
Northern California (1873)
Obesity (294)
Opinion (204)
Patents (131)
People (57966)
Phase I (20931)
Phase II (29425)
Phase III (21748)
Pipeline (615)
Postmarket research (2599)
Preclinical (8944)
Radiopharmaceuticals (254)
Rare diseases (299)
Real estate (6001)
Regulatory (22209)
Research institute (2407)
Resumes & cover letters (351)
Southern California (1623)
Startups (3751)
United States (16852)
Vaccines (589)
Weight loss (209)
Date
Today (99)
Last 7 days (897)
Last 30 days (2185)
Last 365 days (36043)
2025 (1397)
2024 (36336)
2023 (41016)
2022 (52276)
2021 (56763)
2020 (54923)
2019 (47419)
2018 (35697)
2017 (33024)
2016 (32346)
2015 (38396)
2014 (32185)
2013 (27109)
2012 (29220)
2011 (29863)
2010 (27992)
Location
Africa (731)
Arizona (210)
Asia (38767)
Australia (6445)
California (4287)
Canada (1540)
China (359)
Colorado (192)
Connecticut (210)
Europe (84544)
Florida (591)
Georgia (141)
Illinois (425)
Indiana (240)
Maryland (692)
Massachusetts (3375)
Michigan (182)
Minnesota (318)
New Jersey (1195)
New York (1204)
North Carolina (838)
Northern California (1873)
Ohio (152)
Pennsylvania (997)
South America (1107)
Southern California (1623)
Texas (616)
Utah (120)
Washington State (440)
705,158 Results for "unicycive therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Biotech Bay
Unicycive Therapeutics Announces Both an Oral and Poster Presentation to be Delivered on UNI-494 at the Upcoming AKI and CRRT Conference
Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that two presentations related to UNI-494 will be presented at the 29th International Conference on Advances in Critical Care Nephrology AKI and CRRT 2024 taking place March 12-15, 2024, in San Diego, CA.
January 29, 2024
·
4 min read
Biotech Bay
Unicycive Therapeutics Announces Orphan Drug Designation Granted for UNI-494 by the U.S. Food and Drug Administration for the Prevention of Delayed Graft Function in Kidney Transplant Patients
Unicycive Therapeutics, Inc. (Nasdaq: UNCY), a clinical-stage biotechnology company developing therapies for patients with kidney disease (the “Company or “Unicycive”), today announced that the U.S. Food and Drug Administration has granted orphan drug designation (ODD) to UNI-494 for the prevention of Delayed Graft Function (DGF) in kidney transplant patients.
March 4, 2024
·
5 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
Roche purchases shares in tender offer for Poseida Therapeutics, Inc.
January 8, 2025
·
5 min read
Press Releases
LPOXY Therapeutics, Inc. Acquires Key Assets from Xeno Biosciences Inc. to Advance C. difficile Prevention Therapy
January 6, 2025
·
3 min read
Press Releases
Exicure, Inc. Partners with GPCR Therapeutics to Fuel New Growth in Biotech
December 26, 2024
·
4 min read
Press Releases
Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
November 25, 2024
·
5 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Biotech Bay
Unicycive to Present at Upcoming March Investor Conferences
Unicycive Therapeutics, Inc. today announced that Shalabh Gupta , M.D., Chief Executive Officer of Unicycive, will participate at two upcoming investor conferences in March.
March 3, 2022
·
1 min read
Press Releases
Tenpoint Therapeutics Ltd. and Visus Therapeutics, Inc. Join Forces, Building the Next Era of Best- and First-in-Class Ophthalmic Medicines
December 12, 2024
·
4 min read
1 of 70,516
Next
